Thrombospondin-1 is induced in rat myocardial infarction and its induction is accelerated by ischemia/reperfusion

Experimental Biology and Medicine

Volumn 230, Issue 9, 2005, Pages 621-630

  Sezaki, Satoshi ^a   Hirohata, Satoshi ^a   Iwabu, Akihiro ^a   Nakamura, Keigo ^a   Toeda, Kenichi ^a   Miyoshi, Toru ^a   Yamawaki, Hitoshi ^a   Demircan, Kadir ^a   Kusachi, Shozo ^b   Shiratori, Yasushi ^a   Ninomiya, Yoshifumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cytokine; Extracellular matrix; Gene expression; Inflammation; Ischemia

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBOSPONDIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE RELEASE; DNA DETERMINATION; DNA ISOLATION; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IN SITU HYBRIDIZATION; MALE; MONONUCLEAR CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALIA;

EID: 27144484944     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523000904     Document Type: Article

References (46)

1. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93:1159-1170, 1998.
2. Agah A, Kyriakides TR, Lawler J, Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol 161:831-839, 2002.
3. Lawler J SM, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101:982-992, 1998.
4. Sheibani N, Frazier WA. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell 9:701-713, 1998.
5. Raugi GJ, Mullen JS, Bark DH, Okada T, Mayberg MR. Thrombospondin deposition in rat carotid artery injury. Am J Pathol 137:179-185, 1990.
6. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, Johnson RJ. Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48:1846-1856, 1995.
7. Kordenat KDJ, Pepper D. Canine thrombospondin (TSP) levels measured in plasma by radioimmunoassay before and during acute coronary thrombosis. Thromb Haemost 49:250, 1983.
8. Ffrench PMJ, Berruyer M, Belleville J, Touboul P, Dawes J, Dechavanne M. Comparative evaluation of plasma thrombospondin beta-thromboglobulin and platelet factor 4 in acute myocardial infarction. Thromb Res 39:619-624, 1985.
9. Nakamura K, Hirohata S, Murakami T, Miyoshi T, Demircan K, Oohashi T, Ogawa H, Koten K, Toeda K, Kusachi S, Ninomiya Y, Shiratori Y. Dynamic Induction of ADAMTS1 Gene in the Early Phase of Acute Myocardial Infarction. J Biochem (Tokyo) 136:439-446, 2004.
10. Apte SS. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 36:981-985, 2004.
11. Fischer JW, Stoll M, Hahn AW, Unger T. Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells. Cardiovasc Res 51:784-791, 2001.
12. Stenina OI, Krukovets I, Wang K, Zhou Z, Forudi F, Penn MS, Topol EJ, Plow EF. Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circulation 107:3209-3215, 2003.
13. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 138:S69-75, 1999.
14. Hirohata S, Wang LW, Miyagi M, Yan L, Seldin MF, Keene DR, Crabb JW, Apte SS. Punctin, a novel ADAMTS-like molecule, ADAMTSL-1, in extracellular matrix. J Biol Chem 277:12182-12189, 2002.
15. Iwabu A, Murakami T, Kusachi S, Nakamura K, Takemoto S, Komatsubara I, Sezaki S, Hayashi J, Ninomiya Y, Tsuji T. Concomitant expression of heparin-binding epidermal growth factorlike growth factor mRNA and basic fibroblast growth factor mRNA in myocardial infarction in rats. Basic Res Cardiol 97:214-222, 2002.
16. Murakami M, Kusachi S, Nakahama M, Naito I, Murakami T, Doi M, Kondo J, Higashi T, Ninomiya Y, Tsuji T. Expression of the alpha 1 and alpha 2 chains of type IV collagen in the infarct zone of rat myocardial infarction. J Mol Cell Cardiol 30:1191-1202, 1998.
17. Yamasaki S, Kusachi S, Moritani H, Kondo J, Hirohata S, Tamura A, Tsuji T. Reperfusion hastens appearance and extent of distribution of type I collagen in infarct zone: immunohistochemical study in rat experimental infarction. Cardiovasc Res 30:763-768, 1995.
18. Komatsubara I, Murakami T, Kusachi S, Nakamura K, Hirohata S, Hayashi J, Takemoto S, Suezawa C, Ninomiya Y, Shiratori Y. Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats. Cardiovasc Pathol 12:186-194, 2003.
19. Fernandes RJ, Hirohata S, Engle JM, Colige A, Cohn DH, Eyre DR, Apte SS. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem 276:31502-31509, 2001.
20. Ohnishi H, Oka T, Kusachi S, Nakanishi T, Takeda K, Nakahama M, Doi M, Murakami T, Ninomiya Y, Takigawa M, Tsuji T. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol 30:2411-2422, 1998.
21. Takemoto S, Murakami T, Kusachi S, Iwabu A, Hirohata S, Nakamura K, Sezaki S, Havashi J, Suezawa C, Ninomiya Y, Tsuji T. Increased expression of dermatopontin mRNA in the infarct zone of experimentally induced myocardial infarction in rats: comparison with decorin and type I collagen mRNAs. Basic Res Cardiol 97:461-468, 2002.
22. Nakahama M, Murakami T, Kusachi S, Naito I, Takeda K, Ohnishi H, Komatsubara I, Oka T, Ninomiya Y, Tsuji T. Expression of perlecan proteoglycan in the infarct zone of mouse myocardial infarction. J Mol Cell Cardiol 32:1087-1100, 2000.
23. Lakkisto P, Palojoki E, Backlund T, Saraste A, Tikkanen I, Voipio-Pulkki LM, Pulkki K. Expression of heme oxygenase-1 in response to myocardial infarction in rats. J Mol Cell Cardiol 34:1357-1365, 2002.
24. Demircan K, Hirohata S, Nishida K, Hatipoglu OF, Oohashi T, Yonezawa T, Apte SS, Ninomiya Y. ADAMTS-9 is synergistically induced by interleukin-1beta and tumor necrosis factor alpha in OUMS-27 chondrosarcoma cells and in human chondrocytes. Arthritis Rheum 52:1451-1460, 2005.
25. Naldini A, Pucci A, Carney DH, Fanetti G, Carraro F. Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1. Cytokine 20:191-199, 2002.
26. Toeda K, Nakamura K, Hirohata S, Hatipoglu O, Demircan K, Yamawaki H, Ogawa H, Kusachi S, Shiratori Y, Ninomiya Y. Versican is induced in infiltrating monocytes in myocardial infarction. Mol Cell Biochem (in press, 2005).
27. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99:546-551, 1999.
28. Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92:1866-1875, 1995.
29. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 109:315-323, 2000.
30. Iruela-Arispe ML, Vazquez F, Ortega MA. Antiangiogenic domains shared by thrombospondins and metallospondins, a new family of angiogenic inhibitors. Ann N Y Acad Sci 886:58-66, 1999.
31. Iruela-Arispe MLLM, Krutzsch HC, Lawler J, Roberts DD. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 100:1423-1431, 1999.
32. Vazquez F, Hastings G, Ortega MA, Lane TF, Oikemus S, Lombardo M, Iruela-Arispe ML. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angioinhibitory activity. J Biol Chem 274:23349-23357, 1999.
33. Deten A, Volz HC, Briest W, Zimmer HG. Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats. Mol Cell Biochem 242:47-55, 2003.
34. Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28:851-858, 1996.
35. Zhao L, Eghbali-Webb M. Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells. Biochim Biophys Acta 1538:273-282, 2001.
36. Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, Delespesse G, Sarfati M. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med 198:1277-1283, 2003.
37. Phelan MWFL, Perrine SP, Faller DV. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med 132:512-529, 1998.
38. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53:31-47, 2002.
39. Tonnessen T, Florholmen G, Henriksen UL, Christensen G. Cardiopulmonary alterations in mRNA expression for interleukin-1beta, the interleukin-6 superfamily and CXC-chemokines during development of postischaemic heart failure in the rat. Clin Physiol Funct Imaging 23:263-268, 2003.
40. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 64:61-71, 2004.
41. Yamauchi Y, Kuroki M, Imakiire T, Abe H, Uchida H, Beppu R, Yamashita Y, Shirakusa T. Thrombospondin-1 differentially regulates release of IL-6 and IL-10 by human monocytic cell line U937. Biochem Biophys Res Commun 290:1551-1557, 2002.
42. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG. CCL2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory Responses Critical to Healing Myocardial Infarcts. Circ Res 96:881-889, 2005.
43. Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 16:1019-1025, 1996.
44. Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 87:2020-2028, 1996.
45. Gosset P, Charbonnier AS, Delerive P, Fontaine J, Staels B, Pestel J, Tonnel AB, Trottein F. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol 31:2857-2865, 2001.
46. Demeure CE, Tanaka H, Mateo V, Rubio M, Delespesse G, Sarfati M. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J Immunol 164:2193-2199, 2000.